PharmaResearch Q3 Net Income Falls 40.5% Year-on-Year

Bitget2026/11/06 00:38

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

PharmaResearch's third-quarter 2026 net profit fell 40.5% year over year to KRW 30.23 billion.
Revenue rose 26.7% from a year earlier to KRW 171.54 billion.
Operating profit increased 1.2% year over year to KRW 62.63 billion.
Sequentially, net profit dropped 46.2%, while operating profit declined 5.8%.
Nine-month net profit reached KRW 135.21 billion, up 4.9% year over year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PharmaResearch Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261106900196), on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

PharmaResearch Q3 Net Income Falls 40.5% Year-on-Year

You may also like

Crypto prices